Magnetic Molecular Energizing (MME) has been used effectively for Avascular Necrosis of Bones.

MME treatment is considered investigational and is utilized under the direction and auspices of an Investigational Review Board (IRB). The IRB complies with FDA requirements for investigational therapy usage and results review. MME therapy is safe and non-invasive. In some cases, patients may experience some tingling, however, most experience no ill effects and can talk, sleep, read or watch TV.

Facts about Avascular Necrosis of Bones

1. Avascular necrosis is a disease resulting from the temporary or permanent loss of blood supply to a bone. It almost always occurs at the end of long bones such as the femur at the hip and knee or the humerus at the shoulder or elbow.
2. It is frequently diagnosed in its early stages with an MRI and later with a standard x-ray. Initially there is a portion of the bone in a joint that appears to have a loose area which in time can collapse and eventually flatten causing uneven pressure within a joint and eventually degenerative arthritis.

Treatment
Surgery to increase the blood flow to the bone is frequently indicated and often with this treatment the process continues to progress. MME may help stimulate the bone to produce blood vessels to assist the healing process. Once collapse has occurred, the magnet may markedly relieve the pain but may not help the collapsed area to regrow to a normal round surface. The magnet time depends on the size of the bone and the stage that is present and would vary from 150 hours for small bone to 200 – 300 hours in larger ones.

Although no absolute assurances can be given, there is good reason for optimism for benefit, in individuals who are accepted for treatment, after review and screening. MME appears to enhance and speed the healing of tissues at the cellular and molecular level.